These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 27610468)

  • 1. An Integrative Model of miRNA and mRNA Expression Signature for Patients of Breast Invasive Carcinoma with Radiotherapy Prognosis.
    Bing Z; Tian J; Zhang J; Li X; Wang X; Yang K
    Cancer Biother Radiopharm; 2016 Sep; 31(7):253-60. PubMed ID: 27610468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of an initial microRNA regulation network in breast invasive carcinoma by bioinformatics analysis.
    Yin Y; Shen C; Xie P; Cheng Z; Zhu Q
    Breast; 2016 Apr; 26():1-10. PubMed ID: 27017236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A three-microRNA signature predicts clinical outcome in breast cancer patients.
    Cheng D; He H; Liang B
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6386-6395. PubMed ID: 30338807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A four-mRNA model to improve the prediction of breast cancer prognosis.
    Qi L; Yao Y; Zhang T; Feng F; Zhou C; Xu X; Sun C
    Gene; 2019 Dec; 721():144100. PubMed ID: 31493508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic microRNA/mRNA signature from the integrated analysis of patients with invasive breast cancer.
    Volinia S; Croce CM
    Proc Natl Acad Sci U S A; 2013 Apr; 110(18):7413-7. PubMed ID: 23589849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A six-gene-based signature for breast cancer radiotherapy sensitivity estimation.
    Chen X; Zheng J; Zhuo ML; Zhang A; You Z
    Biosci Rep; 2020 Dec; 40(12):. PubMed ID: 33179733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic and immune implications of a novel 7-methylguanosine-related microRNA signature in breast invasive carcinoma: from exploration to validation.
    Li AY; Xiao HN; Zhao ZY; Xiang C; Chen ZY; Wang PX; Xia Y; Yu B; Li H; Xiao T
    J Cancer Res Clin Oncol; 2023 Sep; 149(11):9105-9128. PubMed ID: 37171615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and RNA expression integrated signature for urothelial bladder cancer prognosis.
    Xiong J; Xiong K; Bing Z
    Cancer Biomark; 2018 Feb; 21(3):535-546. PubMed ID: 29226853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A radiosensitivity gene signature and PD-L1 status predict clinical outcome of patients with invasive breast carcinoma in The Cancer Genome Atlas (TCGA) dataset.
    Jang BS; Kim IA
    Radiother Oncol; 2017 Sep; 124(3):403-410. PubMed ID: 28579282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Three-mRNA Signature Associated with Pyrimidine Metabolism for Prognosis of BRCA.
    Zhang X; Zhang Q; Xie X; Li Y; Pang Z; Yu T
    Biomed Res Int; 2022; 2022():7201963. PubMed ID: 35224098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated Survival Analysis of mRNA and microRNA Signature of Patients with Breast Cancer Based on Cox Model.
    Zhang W; Zhang Y
    J Comput Biol; 2020 Sep; 27(9):1486-1494. PubMed ID: 32191499
    [No Abstract]   [Full Text] [Related]  

  • 12. A lymph node metastasis-related protein-coding genes combining with long noncoding RNA signature for breast cancer survival prediction.
    Sui Y; Ju C; Shao B
    J Cell Physiol; 2019 Nov; 234(11):20036-20045. PubMed ID: 30950057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An integrated model of clinical information and gene expression for prediction of survival in ovarian cancer patients.
    Yang R; Xiong J; Deng D; Wang Y; Liu H; Jiang G; Peng Y; Peng X; Zeng X
    Transl Res; 2016 Jun; 172():84-95.e11. PubMed ID: 27059002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A four-gene signature in the tumor microenvironment that significantly associates with the prognosis of patients with breast cancer.
    Wang J; Yang Z; Zhang C; Ouyang J; Zhang G; Wu C
    Gene; 2020 Nov; 761():145049. PubMed ID: 32791092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward the precision breast cancer survival prediction utilizing combined whole genome-wide expression and somatic mutation analysis.
    Zhang Y; Yang W; Li D; Yang JY; Guan R; Yang MQ
    BMC Med Genomics; 2018 Nov; 11(Suppl 5):104. PubMed ID: 30454048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of GMI signature based random survival forest prognosis model to predict clinical outcome in acute myeloid leukemia.
    Shi M; Xu G
    BMC Med Genomics; 2019 Jun; 12(1):90. PubMed ID: 31242922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
    Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
    Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miRNA expression in breast cancer varies with lymph node metastasis and other clinicopathologic features.
    Wang B; Li J; Sun M; Sun L; Zhang X
    IUBMB Life; 2014 May; 66(5):371-7. PubMed ID: 24846313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level.
    Xu C; Yamamoto-Ibusuki M; Yamamoto Y; Yamamoto S; Fujiwara S; Murakami K; Okumura Y; Yamaguchi L; Fujiki Y; Iwase H
    Breast Cancer; 2014 Jul; 21(4):482-90. PubMed ID: 22968628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The modularity and dynamicity of miRNA-mRNA interactions in high-grade serous ovarian carcinomas and the prognostic implication.
    Zhang W; Edwards A; Fan W; Flemington EK; Zhang K
    Comput Biol Chem; 2016 Aug; 63():3-14. PubMed ID: 26949157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.